Noninvasive prenatal diagnosis of Down syndrome: Current knowledge and novel insights

Journal of Perinatal Medicine

Volumn 40, Issue 4, 2012, Pages 319-327

  Sifakis, Stavros ^a   Papantoniou, Nikos ^b   Kappou, Dimitra ^a   Antsaklis, Aris ^b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cell free fetal DNA; Down syndrome; Fetal cells; Fetal nucleic acids in maternal circulation; Noninvasive prenatal diagnosis; Trisomy 21

Indexed keywords

MESSENGER RNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

AMNIOCENTESIS; APOPTOSIS; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME 21; CLINICAL ASSESSMENT; CPG ISLAND; DNA CONTENT; DNA METHYLATION; DNA SEQUENCE; DOWN SYNDROME; EPIGENETICS; FALSE POSITIVE RESULT; FETUS KARYOTYPING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HETEROZYGOSITY; HUMAN; NON INVASIVE PRENATAL DIAGNOSIS; NON INVASIVE PROCEDURE; OPEN READING FRAME; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; Y CHROMOSOME;

CHROMOSOMES, HUMAN, PAIR 21; DNA; DOWN SYNDROME; EPIGENESIS, GENETIC; FEMALE; FETUS; GENETIC MARKERS; HUMANS; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RNA; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

EID: 84869484158     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2011-0282     Document Type: Article

References (50)

1. AdinolfiM, Sherlock J. Fetal cells in transcervical samples at an early stage of gestation. J Hum Genet. 2001;46: 99-104. (Pubitemid 32290636)
2. Alberry MS, Soothill PW. Non-invasive prenatal diagnosis: implications for antenatal diagnosis and management of highrisk pregnancies. Semin Fetal Neonatal Med. 2008;13: 84-90.
3. Antsaklis A, Papantoniou N, Xygakis A, Mesogitis S, Tzortzis E, Michalas S. Genetic amniocentesis in women 20-34 years old: associated risks. Prenat Diagn. 2000;20: 247-50. (Pubitemid 30168836)
4. Babochkina T, Mergenthaler S, De Napoli G, Hristoskova S, Tercanli S, Holzgreve W, et al. Numerous erythroblasts in maternal blood are impervious to fluorescent in situ hybridization analysis, a feature related to a dense compact nucleus with apoptotic character. Haematologica. 2005;90: 740-5. (Pubitemid 40897215)
5. Bianchi DW. Fetal cells in the maternal circulation: feasibility for prenatal diagnosis. Br J Haematol. 1999;105: 574-83. (Pubitemid 29277009)
6. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JHM, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA. 1990;87: 3279-83. (Pubitemid 20173618)
7. Bianchi DW, Zickwolf GK, Weit GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA. 1996;93: 705-8. (Pubitemid 26041153)
8. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet. 1997;61: 822-9. (Pubitemid 27418456)
9. Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, Evans MI, et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn. 2002;22: 609-15. (Pubitemid 34839302)
10. Centra M, Picchiassi E, Bini V, Tarquini F, Pennacchi L, Koutras I, et al. Diagnostic accuracy of non-invasive prenatal sex determination: a large-scale study. Clin Genet. 2011;80: 595-7.
11. Chim SSC, Jin S, Lee TYH, Lun FMF, Lee WS, Chan LYS, et al. Systematic search for placental epigenetic markers on chromosome 21: towards noninvasive prenatal diagnosis of fetal trisomy 21. Clin Chem. 2008;54: 500-11. (Pubitemid 351348156)
12. Chinnapapagari SK, Holzgreve W, Lapaire O, Zimmermann B, Hahn S. Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clin Chem. 2005;51: 652-5. (Pubitemid 40300248)
13. Chiu RWK, Chan KCA, Gao Y, Lau VYM, Zheng W, Leung TY, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA. 2008;105: 20458-63.
14. Chiu RWK, Sun H, Akolekar R, Clouser C, Lee C, McKerman K, et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem. 2010;54: 459-63.
15. Chiu RWK, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br Med J. 2011;342:c7401.
16. Costa JM, Gautier E, Benachi A. Genetic analysis of the fetus using maternal blood. Gynecol Obstet Fertil. 2004;32: 646-50. (Pubitemid 39178121)
17. Dhallan R, Au WC, Mattagajasingh S, Emche S, Bayliss P, Damewood M, et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. J Am Med Assoc. 2004;291: 1114-9. (Pubitemid 38541689)
18. Dhallan R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet. 2007;369: 474-81. (Pubitemid 46217810)
19. Driscoll DA, Gross S. Clinical practice. Prenatal screening for aneuploidy. N Engl J Med. 2009;360: 2556-62.
20. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol. 2011;204:205.e1-11.
21. Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem. 2007;79: 7576-9. (Pubitemid 47606128)
22. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA. 2008;105: 16266-71.
23. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing. Clin Chem. 2010;56: 1279-86.
24. Farina A, LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T, Neveux LM, et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem. 2003;49: 239-42. (Pubitemid 36143444)
25. Farina A, LeShane ES, Romero R, Gomez R, Chaiworapongsa T, Rizzo N, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2005;193: 421-5. (Pubitemid 41159536)
26. Gerovassili A, Garner C, Nicolaides KH, Thein SL, Rees DC. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? Prenat Diagn. 2007;27: 104-10. (Pubitemid 46293925)
27. Go AT, Visser A, Betsalel OT, Blankenstein MA, Vugt JM, Oudejans CB. Measurement of allelic-expression ratios in trisomy 21 placentas by quencher extension of heterozygous samples identified by partially denaturing HPLC. Clin Chem. 2008;54: 437-40. (Pubitemid 351302641)
28. Go AT, van Vugt JM, Oudejans CB. Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities. Hum Reprod Update. 2011;17: 372-82.
29. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008;31: 618-24.
30. Kolialexi A, Vrettou C, Traeger-Synodinos J, Burgemeister R, Papantoniou N, Kanavakis E, et al. Noninvasive prenatal diagnosis of beta-thalassaemia using individual fetal erythroblasts isolated from maternal blood after enrichment. Prenat Diagn. 2007;27: 1228-32. (Pubitemid 350305439)
31. Koumantaki Y, Sifakis S, Dragatis G, Matalliotakis I, Froudarakis G, Papadopoulou E, et al. Microsatellite analysis provides efficient confirmation of fetal trophoblast isolation from maternal circulation. Prenat Diagn. 2001;21: 566-70. (Pubitemid 32743514)
32. Lo YM. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. B J Obstet Gynaecol. 2009;116: 152-7.
33. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350: 485-7. (Pubitemid 27343304)
34. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62: 768-75. (Pubitemid 28194317)
35. Lo YMD, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med. 2007;13: 218-23.
36. Lo YMD, Lun FMF, Chan KCA, Tsui NB, Chong KC, Lau TK, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA. 2007;104: 13116-21. (Pubitemid 351737602)
37. Old RW, Crea F, Puszyk W, Hultén MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online. 2007;15: 227-35. (Pubitemid 47263333)
38. Oudejans CB, Go AT, Visser A, Mulders MA, Westerman BA, Blankenstein MA, et al. Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem. 2003;49: 1445-9. (Pubitemid 37011731)
39. Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med. 2011;17: 510-3.
40. Picchiassi E, Coata G, Centra M, Pennacchi L, Bini V, Di Renzo GC. Identification of universal mRNA markers for noninvasive prenatal screening of trisomies. Prenat Diagn. 2010;30: 764-70.
41. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem. 2000;46: 1832-4.
42. Sifakis S, Zaravinos A, Maiz N, Spandidos DA, Nicolaides KH. First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol. 2009;201:427.e1-7.
43. Sifakis S, Ghatpande S, Seppo A, Kilpatrick MW, Tafas T, Tsipouras P, et al. Prenatal diagnosis of trisomy 21 through detection of trophoblasts in cervical smears. Early Hum Dev. 2010;86: 311-3.
44. Tong YK, Jin S, Chiu RW, Ding C, Chan KC, Leung TY, et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic- genetic chromosome-dosage approach. Clin Chem. 2010;56: 90-8.
45. Tounta G, Vrettou C, Kolialexi A, Papantoniou N, Destouni A, Tsangaris GT, et al. A multiplex PCR for non-invasive fetal RHD genotyping using cell-free fetal DNA. In Vivo. 2011;25: 411-7.
46. Tsui DW, Chiu RW, Lo YD. Epigenetic approaches for the detection of fetal DNA in maternal plasma. Chimerism. 2010:1: 30-5.
47. Tsui NB, Akolekar R, Chiu RW, Chow KC, Leung TY, Lau TK, et al. Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem. 2010;56: 73-81.
48. Wright CF, Burton H. The used of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update. 2009;15: 139-51.
49. Zhang Y, Li Q, Hui N, Fei M, Hu Z, Sun S. Effect of formaldehyde treatment on the recovery of cell-free fetal DNA from maternal plasma at different processing times. Clin Chim Acta. 2008;397: 60-4.
50. Zimmermann BG, Grill S, Holzgreve W, Zhong XY, Jackson LG, Hahn S. Digital PCR: a powerful new tool for noninvasive prenatal diagnosis? Prenat Diagn. 2008;28: 1087-93.